nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—CYP1A2—Leflunomide—rheumatoid arthritis	0.0848	0.217	CbGbCtD
Dopamine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0764	0.195	CbGbCtD
Dopamine—CYP2C19—Prednisone—rheumatoid arthritis	0.0454	0.116	CbGbCtD
Dopamine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.043	0.11	CbGbCtD
Dopamine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0358	0.0914	CbGbCtD
Dopamine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0327	0.0835	CbGbCtD
Dopamine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.0283	0.0724	CbGbCtD
Dopamine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0236	0.0602	CbGbCtD
Dopamine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0215	0.055	CbGbCtD
Dopamine—Azotaemia—Ergocalciferol—rheumatoid arthritis	0.0167	0.142	CcSEcCtD
Dopamine—Extravasation—Penicillamine—rheumatoid arthritis	0.00768	0.0654	CcSEcCtD
Dopamine—Isoprenaline—ADRBK1—rheumatoid arthritis	0.0074	0.249	CrCbGaD
Dopamine—Masoprocol—ALOX5—rheumatoid arthritis	0.00624	0.21	CrCbGaD
Dopamine—Epinephrine—ADRBK1—rheumatoid arthritis	0.00622	0.209	CrCbGaD
Dopamine—Azotaemia—Cyclosporine—rheumatoid arthritis	0.00477	0.0406	CcSEcCtD
Dopamine—Mesalazine—ALOX5—rheumatoid arthritis	0.00455	0.153	CrCbGaD
Dopamine—Hypertension—Ergocalciferol—rheumatoid arthritis	0.00336	0.0286	CcSEcCtD
Dopamine—Mesalazine—MPO—rheumatoid arthritis	0.00293	0.0985	CrCbGaD
Dopamine—Necrosis—Hydrocortisone—rheumatoid arthritis	0.00288	0.0245	CcSEcCtD
Dopamine—Necrosis—Methylprednisolone—rheumatoid arthritis	0.00271	0.023	CcSEcCtD
Dopamine—Azotaemia—Methotrexate—rheumatoid arthritis	0.00264	0.0225	CcSEcCtD
Dopamine—Anxiety—Penicillamine—rheumatoid arthritis	0.00249	0.0212	CcSEcCtD
Dopamine—Necrosis—Betamethasone—rheumatoid arthritis	0.00246	0.0209	CcSEcCtD
Dopamine—Necrosis—Dexamethasone—rheumatoid arthritis	0.00246	0.0209	CcSEcCtD
Dopamine—Extravasation—Dexamethasone—rheumatoid arthritis	0.00221	0.0188	CcSEcCtD
Dopamine—Extravasation—Betamethasone—rheumatoid arthritis	0.00221	0.0188	CcSEcCtD
Dopamine—Necrosis—Prednisone—rheumatoid arthritis	0.00214	0.0182	CcSEcCtD
Dopamine—Angina pectoris—Leflunomide—rheumatoid arthritis	0.00201	0.0171	CcSEcCtD
Dopamine—Cyanosis—Methotrexate—rheumatoid arthritis	0.00199	0.0169	CcSEcCtD
Dopamine—Nausea—Ergocalciferol—rheumatoid arthritis	0.00189	0.0161	CcSEcCtD
Dopamine—Necrosis—Methotrexate—rheumatoid arthritis	0.00179	0.0152	CcSEcCtD
Dopamine—Vomiting—Auranofin—rheumatoid arthritis	0.00165	0.014	CcSEcCtD
Dopamine—Extravasation—Methotrexate—rheumatoid arthritis	0.00161	0.0137	CcSEcCtD
Dopamine—Nausea—Auranofin—rheumatoid arthritis	0.00154	0.0131	CcSEcCtD
Dopamine—Vomiting—Penicillamine—rheumatoid arthritis	0.00152	0.0129	CcSEcCtD
Dopamine—Nausea—Penicillamine—rheumatoid arthritis	0.00142	0.0121	CcSEcCtD
Dopamine—Epinephrine—TNF—rheumatoid arthritis	0.00133	0.0448	CrCbGaD
Dopamine—Palpitations—Leflunomide—rheumatoid arthritis	0.00127	0.0108	CcSEcCtD
Dopamine—Hypertension—Leflunomide—rheumatoid arthritis	0.00124	0.0106	CcSEcCtD
Dopamine—Anxiety—Leflunomide—rheumatoid arthritis	0.00122	0.0104	CcSEcCtD
Dopamine—Bradycardia—Prednisolone—rheumatoid arthritis	0.00118	0.0101	CcSEcCtD
Dopamine—Bradycardia—Hydrocortisone—rheumatoid arthritis	0.00116	0.00984	CcSEcCtD
Dopamine—Tachycardia—Leflunomide—rheumatoid arthritis	0.00115	0.00977	CcSEcCtD
Dopamine—Mesalazine—PTGS2—rheumatoid arthritis	0.0011	0.0369	CrCbGaD
Dopamine—Bradycardia—Triamcinolone—rheumatoid arthritis	0.00109	0.00926	CcSEcCtD
Dopamine—Bradycardia—Methylprednisolone—rheumatoid arthritis	0.00109	0.00924	CcSEcCtD
Dopamine—Dyspnoea—Leflunomide—rheumatoid arthritis	0.00105	0.00892	CcSEcCtD
Dopamine—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000987	0.0084	CcSEcCtD
Dopamine—Bradycardia—Betamethasone—rheumatoid arthritis	0.000987	0.0084	CcSEcCtD
Dopamine—Hypertension—Cyclosporine—rheumatoid arthritis	0.00096	0.00817	CcSEcCtD
Dopamine—Anxiety—Cyclosporine—rheumatoid arthritis	0.000943	0.00803	CcSEcCtD
Dopamine—Hypertension—Prednisolone—rheumatoid arthritis	0.000873	0.00744	CcSEcCtD
Dopamine—Bradycardia—Prednisone—rheumatoid arthritis	0.00086	0.00732	CcSEcCtD
Dopamine—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000853	0.00726	CcSEcCtD
Dopamine—Anxiety—Hydrocortisone—rheumatoid arthritis	0.000838	0.00714	CcSEcCtD
Dopamine—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000809	0.00689	CcSEcCtD
Dopamine—Tachycardia—Prednisolone—rheumatoid arthritis	0.000806	0.00686	CcSEcCtD
Dopamine—Hypertension—Triamcinolone—rheumatoid arthritis	0.000803	0.00684	CcSEcCtD
Dopamine—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000801	0.00682	CcSEcCtD
Dopamine—Vomiting—Azathioprine—rheumatoid arthritis	0.000791	0.00674	CcSEcCtD
Dopamine—Anxiety—Methylprednisolone—rheumatoid arthritis	0.000787	0.0067	CcSEcCtD
Dopamine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000787	0.0067	CcSEcCtD
Dopamine—Headache—Azathioprine—rheumatoid arthritis	0.00078	0.00664	CcSEcCtD
Dopamine—Vomiting—Leflunomide—rheumatoid arthritis	0.000747	0.00636	CcSEcCtD
Dopamine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000741	0.00631	CcSEcCtD
Dopamine—Nausea—Azathioprine—rheumatoid arthritis	0.000739	0.0063	CcSEcCtD
Dopamine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000739	0.00629	CcSEcCtD
Dopamine—Headache—Leflunomide—rheumatoid arthritis	0.000736	0.00627	CcSEcCtD
Dopamine—Hypertension—Betamethasone—rheumatoid arthritis	0.000729	0.0062	CcSEcCtD
Dopamine—Hypertension—Dexamethasone—rheumatoid arthritis	0.000729	0.0062	CcSEcCtD
Dopamine—Anxiety—Dexamethasone—rheumatoid arthritis	0.000716	0.0061	CcSEcCtD
Dopamine—Anxiety—Betamethasone—rheumatoid arthritis	0.000716	0.0061	CcSEcCtD
Dopamine—Nausea—Leflunomide—rheumatoid arthritis	0.000698	0.00595	CcSEcCtD
Dopamine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000677	0.00576	CcSEcCtD
Dopamine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000672	0.00572	CcSEcCtD
Dopamine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000672	0.00572	CcSEcCtD
Dopamine—Hypertension—Prednisone—rheumatoid arthritis	0.000635	0.0054	CcSEcCtD
Dopamine—Anxiety—Prednisone—rheumatoid arthritis	0.000624	0.00531	CcSEcCtD
Dopamine—Tachycardia—Prednisone—rheumatoid arthritis	0.000585	0.00499	CcSEcCtD
Dopamine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000577	0.00491	CcSEcCtD
Dopamine—Headache—Cyclosporine—rheumatoid arthritis	0.000568	0.00484	CcSEcCtD
Dopamine—Nausea—Cyclosporine—rheumatoid arthritis	0.000539	0.00459	CcSEcCtD
Dopamine—Headache—Prednisolone—rheumatoid arthritis	0.000517	0.0044	CcSEcCtD
Dopamine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000513	0.00436	CcSEcCtD
Dopamine—Headache—Hydrocortisone—rheumatoid arthritis	0.000505	0.0043	CcSEcCtD
Dopamine—Nausea—Prednisolone—rheumatoid arthritis	0.00049	0.00418	CcSEcCtD
Dopamine—Vomiting—Triamcinolone—rheumatoid arthritis	0.000483	0.00411	CcSEcCtD
Dopamine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000482	0.0041	CcSEcCtD
Dopamine—Nausea—Hydrocortisone—rheumatoid arthritis	0.000479	0.00408	CcSEcCtD
Dopamine—Headache—Triamcinolone—rheumatoid arthritis	0.000476	0.00405	CcSEcCtD
Dopamine—Headache—Methylprednisolone—rheumatoid arthritis	0.000475	0.00404	CcSEcCtD
Dopamine—Nausea—Triamcinolone—rheumatoid arthritis	0.000451	0.00384	CcSEcCtD
Dopamine—Nausea—Methylprednisolone—rheumatoid arthritis	0.00045	0.00383	CcSEcCtD
Dopamine—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000447	0.00381	CcSEcCtD
Dopamine—Vomiting—Betamethasone—rheumatoid arthritis	0.000438	0.00373	CcSEcCtD
Dopamine—Vomiting—Dexamethasone—rheumatoid arthritis	0.000438	0.00373	CcSEcCtD
Dopamine—Headache—Dexamethasone—rheumatoid arthritis	0.000432	0.00367	CcSEcCtD
Dopamine—Headache—Betamethasone—rheumatoid arthritis	0.000432	0.00367	CcSEcCtD
Dopamine—Nausea—Betamethasone—rheumatoid arthritis	0.000409	0.00348	CcSEcCtD
Dopamine—Nausea—Dexamethasone—rheumatoid arthritis	0.000409	0.00348	CcSEcCtD
Dopamine—Vomiting—Prednisone—rheumatoid arthritis	0.000381	0.00325	CcSEcCtD
Dopamine—Headache—Prednisone—rheumatoid arthritis	0.000376	0.0032	CcSEcCtD
Dopamine—Nausea—Prednisone—rheumatoid arthritis	0.000356	0.00303	CcSEcCtD
Dopamine—Vomiting—Methotrexate—rheumatoid arthritis	0.000319	0.00271	CcSEcCtD
Dopamine—Headache—Methotrexate—rheumatoid arthritis	0.000314	0.00267	CcSEcCtD
Dopamine—Nausea—Methotrexate—rheumatoid arthritis	0.000298	0.00254	CcSEcCtD
Dopamine—DRD1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.85e-05	8.35e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTK2—rheumatoid arthritis	3.83e-05	8.3e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PTGS2—rheumatoid arthritis	3.83e-05	8.3e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SPP1—rheumatoid arthritis	3.82e-05	8.28e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.81e-05	8.27e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP3—rheumatoid arthritis	3.81e-05	8.25e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.8e-05	8.25e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—LEP—rheumatoid arthritis	3.8e-05	8.25e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.8e-05	8.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.78e-05	8.2e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.78e-05	8.2e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCR5—rheumatoid arthritis	3.76e-05	8.16e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MTHFR—rheumatoid arthritis	3.76e-05	8.16e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—POMC—rheumatoid arthritis	3.76e-05	8.15e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL5—rheumatoid arthritis	3.76e-05	8.14e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—FN1—rheumatoid arthritis	3.75e-05	8.12e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6ST—rheumatoid arthritis	3.73e-05	8.09e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT1—rheumatoid arthritis	3.72e-05	8.06e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCR5—rheumatoid arthritis	3.71e-05	8.05e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.71e-05	8.04e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CSF2—rheumatoid arthritis	3.7e-05	8.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL2—rheumatoid arthritis	3.68e-05	7.98e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCL2—rheumatoid arthritis	3.68e-05	7.98e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—C3—rheumatoid arthritis	3.68e-05	7.97e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6R—rheumatoid arthritis	3.67e-05	7.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL10—rheumatoid arthritis	3.66e-05	7.94e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTK2—rheumatoid arthritis	3.66e-05	7.94e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2RA—rheumatoid arthritis	3.66e-05	7.93e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.65e-05	7.91e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—IL2—rheumatoid arthritis	3.64e-05	7.9e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—BGN—rheumatoid arthritis	3.64e-05	7.89e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL2—rheumatoid arthritis	3.63e-05	7.87e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—C3—rheumatoid arthritis	3.63e-05	7.87e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CD80—rheumatoid arthritis	3.59e-05	7.79e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL5—rheumatoid arthritis	3.59e-05	7.79e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—FN1—rheumatoid arthritis	3.59e-05	7.78e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6ST—rheumatoid arthritis	3.57e-05	7.75e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—POMC—rheumatoid arthritis	3.56e-05	7.72e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CSF2—rheumatoid arthritis	3.54e-05	7.67e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MTHFR—rheumatoid arthritis	3.51e-05	7.6e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	3.51e-05	7.6e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.49e-05	7.56e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SPP1—rheumatoid arthritis	3.48e-05	7.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.46e-05	7.51e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.45e-05	7.48e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.45e-05	7.48e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CD80—rheumatoid arthritis	3.44e-05	7.46e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CXCL8—rheumatoid arthritis	3.42e-05	7.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—LEP—rheumatoid arthritis	3.42e-05	7.42e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—POMC—rheumatoid arthritis	3.41e-05	7.4e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCR5—rheumatoid arthritis	3.38e-05	7.34e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—LEP—rheumatoid arthritis	3.38e-05	7.32e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	3.35e-05	7.27e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP3—rheumatoid arthritis	3.34e-05	7.25e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.34e-05	7.24e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL2—rheumatoid arthritis	3.34e-05	7.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.33e-05	7.23e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6R—rheumatoid arthritis	3.33e-05	7.22e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SPP1—rheumatoid arthritis	3.33e-05	7.21e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.31e-05	7.18e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL2—rheumatoid arthritis	3.31e-05	7.18e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—C3—rheumatoid arthritis	3.31e-05	7.17e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL2—rheumatoid arthritis	3.27e-05	7.1e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—POMC—rheumatoid arthritis	3.27e-05	7.08e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—rheumatoid arthritis	3.26e-05	7.06e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ALB—rheumatoid arthritis	3.24e-05	7.03e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCR5—rheumatoid arthritis	3.24e-05	7.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—FN1—rheumatoid arthritis	3.23e-05	7e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	3.22e-05	6.99e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTK2—rheumatoid arthritis	3.22e-05	6.97e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.22e-05	6.97e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.2e-05	6.94e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL2—rheumatoid arthritis	3.2e-05	6.93e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	3.2e-05	6.93e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2RA—rheumatoid arthritis	3.19e-05	6.92e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6R—rheumatoid arthritis	3.19e-05	6.91e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—FN1—rheumatoid arthritis	3.19e-05	6.91e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6ST—rheumatoid arthritis	3.17e-05	6.88e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL2—rheumatoid arthritis	3.17e-05	6.86e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—C3—rheumatoid arthritis	3.16e-05	6.86e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL5—rheumatoid arthritis	3.15e-05	6.84e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.14e-05	6.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CSF2—rheumatoid arthritis	3.11e-05	6.74e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—NOS3—rheumatoid arthritis	3.1e-05	6.73e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MMP9—rheumatoid arthritis	3.1e-05	6.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CD80—rheumatoid arthritis	3.1e-05	6.71e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—LEP—rheumatoid arthritis	3.08e-05	6.67e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NFKB1—rheumatoid arthritis	3.06e-05	6.64e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—IL2—rheumatoid arthritis	3.06e-05	6.64e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CD80—rheumatoid arthritis	3.05e-05	6.62e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TYK2—rheumatoid arthritis	3.03e-05	6.58e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.02e-05	6.54e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MAPK8—rheumatoid arthritis	3.01e-05	6.53e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—POMC—rheumatoid arthritis	3.01e-05	6.52e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOS3—rheumatoid arthritis	2.98e-05	6.45e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.95e-05	6.39e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—LEP—rheumatoid arthritis	2.94e-05	6.38e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—POMC—rheumatoid arthritis	2.94e-05	6.38e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	2.92e-05	6.33e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.91e-05	6.31e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TYK2—rheumatoid arthritis	2.9e-05	6.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FN1—rheumatoid arthritis	2.9e-05	6.29e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—POMC—rheumatoid arthritis	2.9e-05	6.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.89e-05	6.27e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL2—rheumatoid arthritis	2.88e-05	6.24e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6R—rheumatoid arthritis	2.87e-05	6.22e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOS3—rheumatoid arthritis	2.85e-05	6.18e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	2.84e-05	6.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL2—rheumatoid arthritis	2.84e-05	6.16e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—rheumatoid arthritis	2.84e-05	6.15e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6R—rheumatoid arthritis	2.83e-05	6.14e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—POMC—rheumatoid arthritis	2.81e-05	6.08e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.8e-05	6.07e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CD80—rheumatoid arthritis	2.78e-05	6.03e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.78e-05	6.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	2.78e-05	6.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—C3—rheumatoid arthritis	2.78e-05	6.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FN1—rheumatoid arthritis	2.78e-05	6.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.77e-05	6e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.75e-05	5.96e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ALB—rheumatoid arthritis	2.74e-05	5.95e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.73e-05	5.92e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.69e-05	5.83e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CD80—rheumatoid arthritis	2.66e-05	5.77e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—POMC—rheumatoid arthritis	2.64e-05	5.73e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CXCL8—rheumatoid arthritis	2.64e-05	5.72e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	2.62e-05	5.69e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TYK2—rheumatoid arthritis	2.61e-05	5.67e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL2—rheumatoid arthritis	2.59e-05	5.61e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	2.59e-05	5.6e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6R—rheumatoid arthritis	2.58e-05	5.59e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	2.58e-05	5.59e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	2.57e-05	5.56e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ALB—rheumatoid arthritis	2.56e-05	5.54e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—rheumatoid arthritis	2.55e-05	5.54e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	2.53e-05	5.49e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	2.53e-05	5.48e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—rheumatoid arthritis	2.53e-05	5.48e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	2.52e-05	5.47e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL2—rheumatoid arthritis	2.52e-05	5.47e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—rheumatoid arthritis	2.51e-05	5.44e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	2.48e-05	5.37e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	2.47e-05	5.35e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	2.45e-05	5.3e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	2.44e-05	5.29e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.43e-05	5.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL2—rheumatoid arthritis	2.42e-05	5.24e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—rheumatoid arthritis	2.4e-05	5.21e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	2.4e-05	5.2e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—rheumatoid arthritis	2.39e-05	5.18e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NFKB1—rheumatoid arthritis	2.36e-05	5.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.35e-05	5.1e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TYK2—rheumatoid arthritis	2.35e-05	5.09e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	2.34e-05	5.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK8—rheumatoid arthritis	2.32e-05	5.04e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	2.32e-05	5.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—rheumatoid arthritis	2.31e-05	5e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	2.3e-05	4.99e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—rheumatoid arthritis	2.29e-05	4.96e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.28e-05	4.93e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NFKB1—rheumatoid arthritis	2.26e-05	4.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	2.25e-05	4.87e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.25e-05	4.87e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	2.24e-05	4.85e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK8—rheumatoid arthritis	2.22e-05	4.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	2.22e-05	4.81e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	2.21e-05	4.78e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	2.17e-05	4.71e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	2.17e-05	4.71e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	2.17e-05	4.7e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	2.16e-05	4.69e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	2.15e-05	4.65e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—rheumatoid arthritis	2.14e-05	4.65e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	2.14e-05	4.63e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	2.11e-05	4.57e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	2.1e-05	4.56e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	2.06e-05	4.46e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	2.05e-05	4.45e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.05e-05	4.44e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.04e-05	4.41e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	2.03e-05	4.4e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.01e-05	4.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	2e-05	4.34e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.98e-05	4.28e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.97e-05	4.28e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—rheumatoid arthritis	1.97e-05	4.27e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.97e-05	4.26e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.96e-05	4.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	1.96e-05	4.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	1.95e-05	4.22e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.94e-05	4.2e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	1.94e-05	4.2e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	1.92e-05	4.17e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.92e-05	4.16e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.88e-05	4.09e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	1.87e-05	4.05e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.86e-05	4.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	1.85e-05	4.01e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.85e-05	4.01e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.83e-05	3.97e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.82e-05	3.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.8e-05	3.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.77e-05	3.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.75e-05	3.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.72e-05	3.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.72e-05	3.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.7e-05	3.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.68e-05	3.65e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.67e-05	3.63e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.66e-05	3.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1.64e-05	3.56e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.64e-05	3.56e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	1.63e-05	3.54e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—rheumatoid arthritis	1.62e-05	3.51e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.59e-05	3.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	1.55e-05	3.37e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	1.55e-05	3.36e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.55e-05	3.36e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.54e-05	3.33e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.54e-05	3.33e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.54e-05	3.33e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.53e-05	3.31e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.51e-05	3.28e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—rheumatoid arthritis	1.48e-05	3.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1.47e-05	3.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.46e-05	3.16e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	1.42e-05	3.08e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.41e-05	3.06e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.4e-05	3.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	1.4e-05	3.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.4e-05	3.03e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	1.38e-05	2.99e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.35e-05	2.93e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.34e-05	2.91e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.34e-05	2.9e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.31e-05	2.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.28e-05	2.78e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	1.28e-05	2.77e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	1.26e-05	2.73e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	1.26e-05	2.72e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.24e-05	2.68e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.23e-05	2.66e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	1.2e-05	2.6e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.2e-05	2.59e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	1.15e-05	2.49e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.14e-05	2.48e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	1.1e-05	2.38e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	1.05e-05	2.29e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	1.05e-05	2.27e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	9.65e-06	2.09e-05	CbGpPWpGaD
